Indivior Pharmaceuticals, Inc. (INDV) insider trading.
In Q3 2026, insiders at Indivior Pharmaceuticals, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 2 open-market purchases worth $108K and 1 sale worth $765K.
- Transactions
- 3
- Purchases (P)
- 2
- Sales (S)
- 1
- Net shares, P minus S
- -15,586
- Insiders
- 2
- Last filed
- 2026-08-27
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Anderson Woodrow D | Officer · Chief Accounting Officer | 2 | 2 | 0 |
| Heidbreder Christian | Officer · Chief Scientific Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Anderson Woodrow D | P (A) | 1,500 | $35.69 | 27,638 | Form 4 |
| 2026-08-05 | Anderson Woodrow D | P (A) | 1,500 | $36.28 | 26,138 | Form 4 |
| 2026-07-10 | Heidbreder Christian | S (D) | 18,586 | $41.14 | 209,337 | Form 4 |
Transaction codes in this quarter
Get INDV insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1625297&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · INDV company page · Indivior Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Indivior Pharmaceuticals, Inc. (INDV)?
In Q3 2026, insiders at Indivior Pharmaceuticals, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 2 open-market purchases worth $108K and 1 sale worth $765K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Indivior Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/indv.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.